Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3342-3352

  Reynolds, Ben C ^a   Turner, Darryl G ^a   Mcpherson, Rhoanne C ^a   Prendergast, Catriona T ^a   Phelps, Richard G ^a   Turner, Neil A ^a   O'Connor, Richard A ^a   Anderton, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Autoimmunity; Cytokines; Immunotherapy; Regulatory T cells; Treg cells

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IL27 PROTEIN, MOUSE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MOUSE; REGULATORY T LYMPHOCYTE; TH1 CELL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-6; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84916918681     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444687     Document Type: Article

References (42)

1. Stephens, L. A., Malpass, K. H. and Anderton, S. M., Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 2009. 39: 1108-1117.
2. Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L. et al., In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1455-1465.
3. DiPaolo, R. J., Brinster, C., Davidson, T. S., Andersson, J., Glass, D. and Shevach, E. M., Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 2007. 179: 4685-4693.
4. Tu, E., Bourges, D., Gleeson, P. A., Ang, D. K. and van Driel, I. R., Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells. Eur. J. Immunol. 2013. 43: 1286-1296.
5. Xu, L., Kitani, A., Fuss, I. and Strober, W., Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 2007. 178: 6725-6729.
6. Zheng, S. G., Wang, J. and Horwitz, D. A., Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 2008. 180: 7112-7116.
7. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B. et al., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008. 29: 44-56.
8. Stroopinsky, D., Avivi, I., Rowe, J. M., Avigan, D. and Katz, T., Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity. Eur. J. Immunol. 2009. 39: 2703-2715.
9. McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmuller, U. et al., Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 2011. 186: 3918-3926.
10. Voo, K. S., Wang, Y. H., Santori, F. R., Boggiano, C., Wang, Y. H., Arima, K., Bover, L. et al., Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 2009. 106: 4793-4798.
11. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. and Joosten, I., Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008. 112: 2340-2352.
12. Deknuydt, F., Bioley, G., Valmori, D. and Ayyoub, M., IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin.Immunol. 2009. 131: 298-307.
13. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M. et al., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009. 10: 1000-1007.
14. Bailey-Bucktrout, S. L., Martinez-Llordella, M., Zhou, X., Anthony, B., Rosenthal, W., Luche, H., Fehling, H. J. et al., Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 2013. 39: 949-962.
15. Sakaguchi, S., Vignali, D. A., Rudensky, A. Y., Niec, R. E. and Waldmann, H., The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 2013. 13: 461-467.
16. O'Connor, R. A., Leech, M. D., Suffner, J., Hammerling, G. J. and Anderton, S. M., Myelin-reactive, TGF-beta-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J. Immunol. 2010. 185: 7235-7243.
17. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. et al., Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996. 156: 5-7.
18. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
19. O'Connor, R. A., Cambrook, H., Huettner, K. and Anderton, S. M., T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease. Eur. J. Immunol. 2013. 43: 2818-2823.
20. Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. et al., RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560-567.
21. O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C. and Anderton, S. M., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2008. 181: 3750-3754.
22. Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D. and Dittel, B. N., GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 39-48.
23. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G. X. et al., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011. 12: 568-575.
24. Young, A., Linehan, E., Hams, E., O'Hara Hall, A. C., McClurg, A., Johnston, J. A., Hunter, C. A. et al., Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27. J. Immunol. 2012. 189: 2079-2083.
25. Feng, T., Cao, A. T., Weaver, C. T., Elson, C. O. and Cong, Y., Interleukin-12 converts Foxp3+ regulatory T cells to interferon-gamma-producing Foxp3+ T cells that inhibit colitis. Gastroenterology 2011. 140: 2031-2043.
26. Sawitzki, B., Kingsley, C. I., Oliveira, V., Karim, M., Herber, M. and Wood, K. J., IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 2005. 201: 1925-1935.
27. Daniel, V., Sadeghi, M., Wang, H. and Opelz, G., In-vitro inhibition of IFNgamma+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function. BMC Immunol. 2012. 13: 47.
28. McGeachy, M. J., Stephens, L. A. and Anderton, S. M., Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 2005. 175: 3025-3032.
29. O'Connor, R. A., Malpass, K. H. and Anderton, S. M., The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J. Immunol. 2007. 179: 958-966.
30. O'Connor, R. A., Floess, S., Huehn, J., Jones, S. A. and Anderton, S. M., Foxp3 (+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production. Eur. J. Immunol. 2012. 42: 1174-1179.
31. Lees, J. R., Golumbek, P. T., Sim, J., Dorsey, D. and Russell, J. H., Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 2008. 205: 2633-2642.
32. Chen, X., Subleski, J. J., Kopf, H., Howard, O. M., Mannel, D. N. and Oppenheim, J. J., Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 2008. 180: 6467-6471.
33. Housley, W. J., Adams, C. O., Nichols, F. C., Puddington, L., Lingenheld, E. G., Zhu, L., Rajan, T. V. et al., Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function. J. Immunol. 2011. 186: 6779-6787.
34. Grinberg-Bleyer, Y., Saadoun, D., Baeyens, A., Billiard, F., Goldstein, J. D., Gregoire, S., Martin, G. H. et al., Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J. Clin. Invest. 2010. 120: 4558-4568.
35. McPherson, R. C. and Anderton, S. M., Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities. J. NeuroimmunePharmacol. 2013. 8: 774-790.
36. Gorelik, L., Constant, S. and Flavell, R. A., Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 2002. 195: 1499-1505.
37. Ince, M. N., Elliott, D. E., Setiawan, T., Metwali, A., Blum, A., Chen, H. L., Urban, J. F. et al., Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur. J. Immunol. 2009. 39: 1870-1878.
38. Okuda, Y., Sakoda, S., Bernard, C. C., Fujimura, H., Saeki, Y., Kishimoto, T. and Yanagihara, T., IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 1998. 10: 703-708.
39. Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S. and Chen, Y., IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 1998. 161: 6480-6486.
40. Leech, M. D., Barr, T. A., Turner, D. G., Brown, S., O'Connor, R. A., Gray, D., Mellanby, R. J. et al., Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source. J. Immunol. 2013. 190: 881-885.
41. Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H. et al., IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2008. 105: 9041-9046.
42. Suffner, J., Hochweller, K., Kuhnle, M. C., Li, X., Kroczek, R. A., Garbi, N. and Hammerling, G. J., Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J. Immunol. 2010. 184: 1810-1820.